MDLinxThe Latest on Kate Middleton’s Cancer Treatment

Royal Cancer Diagnosis Highlights Increasing Incidence of Abdominal Cancers in Younger Patients

Catherine, Princess of Wales, aged 42, has been undergoing treatment for an unspecified type of cancer discovered following abdominal surgery earlier this year. Her experience sheds light on the use of preventative chemotherapy and its impact on patients’ daily lives. Her case also highlights the increasing prevalence of cancer diagnoses in younger individuals, particularly abdominal cancers.

Key Points:

• Catherine, Princess of Wales, was diagnosed with cancer after planned abdominal surgery in January 2024.
• She is currently undergoing preventative chemotherapy, which began in March 2024.
• The Princess reported experiencing fatigue and weakness as side effects of her treatment.
• Her chemotherapy regimen is expected to continue for several more months.
• Experts suggest that the use of chemotherapy may indicate that the cancer has spread beyond its origin.
• The term “preventative chemotherapy” is often used interchangeably with “adjuvant chemotherapy.”
• Adjuvant chemotherapy is typically administered after surgery to reduce the risk of recurrence or improve survival chances.
• Common side effects of chemotherapy include fatigue, hair loss, skin issues, gastrointestinal symptoms, and changes in food taste.
• Patients undergoing chemotherapy may experience isolation, depression, and anxiety due to treatment-related stress.
• Many cancer patients take medical leave from work during treatment due to side effects and weakened immune systems.
• Abdominal cancers are becoming more common, even in younger individuals.
• The Princess’s case highlights that cancer is no longer exclusively an “older person’s disease.”

“When cancer is in situ or has not broken out of the place of origin beyond the initial layers of tissue, chemotherapy is hardly ever recommended, so that may speak to the stage, aggressiveness, or potential for progression of the disease.”
– Monique Gary, DO, MSc, FACS; Breast Surgical Oncologist

More on Chemotherapy